Inventor · disambiguated record
Ketan Mehta
Also filed as: MEHTA KETAN · MEHTA KETAN C
59 granted patents·19 pending applications·2,292 citations·filing 2001–2024
99Inventor score
Top patents by PatentIndex Score
78 records- 0199US10933143B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Mar 2, 2021·36 cites·22 claims
- 0299US10668163B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Granted Jun 2, 2020·36 cites·27 claims
- 0399US10172958B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 8, 2019·37 cites·23 claims
- 0499US10086087B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2017·Granted Oct 2, 2018·36 cites·22 claims
- 0599US9675703B2Modified release formulations containing drug - ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·21 claims
- 0699US9675704B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jun 13, 2017·49 cites·20 claims
- 0799US9549989B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2016·Granted Jan 24, 2017·40 cites·14 claims
- 0899US9522191B2Modified release formulations containing drug—ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Dec 20, 2016·40 cites·19 claims
- 0999US9198864B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2015·Granted Dec 1, 2015·55 cites·14 claims
- 1099US8883217B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2014·Granted Nov 11, 2014·57 cites·18 claims
- 1199US8790700B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jul 29, 2014·70 cites·29 claims
- 1299US8747902B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Jun 10, 2014·70 cites·30 claims
- 1399US8597684B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2013·Granted Dec 3, 2013·77 cites·29 claims
- 1499US8491935B2Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2012·Granted Jul 23, 2013·95 cites·24 claims
- 1598US9040083B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted May 26, 2015·51 cites·22 claims
- 1698US8956649B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2014·Granted Feb 17, 2015·51 cites·43 claims
- 1798US8778390B2Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Jul 15, 2014·62 cites·30 claims
- 1898US8623409B1Clonidine formulationMEHTA KETAN·Filed 2010·Granted Jan 7, 2014·60 cites·28 claims
- 1998US8563033B1Orally effective methylphenidate extended release powder and aqueous suspension productTRIS PHARMA INC·Filed 2013·Granted Oct 22, 2013·67 cites·19 claims
- 2098US8465765B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2012·Granted Jun 18, 2013·71 cites·30 claims
- 2198US8337890B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2010·Granted Dec 25, 2012·79 cites·29 claims
- 2298US8287903B2Orally effective methylphenidate extended release powder and aqueous suspension productMEHTA KETAN·Filed 2011·Granted Oct 16, 2012·88 cites·30 claims
- 2398US8202537B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2011·Granted Jun 19, 2012·94 cites·24 claims
- 2498US8062667B2Modified release formulations containing drug-ion exchange resin complexesMEHTA KETAN·Filed 2007·Granted Nov 22, 2011·119 cites·55 claims
- 2596US8512688B2Formulations containing an ionic mineral-ion exchange resin complex and uses thereofMEHTA KETAN·Filed 2012·Granted Aug 20, 2013·68 cites·19 claims
- 2696US8287848B2Formulations containing an ionic mineral-ion exchange resin complex and uses thereofMEHTA KETAN·Filed 2007·Granted Oct 16, 2012·87 cites·24 claims
- 2796US8202542B1Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatingsMEHTA KETAN·Filed 2008·Granted Jun 19, 2012·132 cites·25 claims
- 2896US7988860B2Superabsorbent-containing web that can act as a filter, absorbent, reactive layer or fuel fuseDONALDSON CO INC·Filed 2008·Granted Aug 2, 2011·47 cites·8 claims
- 2995US8263214B2Super absorbent containing web that can act as a filter, absorbent, reactive layer or fuel fuseKALAYCI VELI E·Filed 2011·Granted Sep 11, 2012·30 cites·24 claims
- 3095US6520384B2Apparatus and method for nasal rinseFiled 2001·Granted Feb 18, 2003·72 cites·34 claims
- 3194USD684259SAmpoule with a translucent structureMEHTA KETAN C·Filed 2011·Granted Jun 11, 2013·22 cites·1 claims
- 3293US8556089B2Super absorbent containing web that can act as a filter, absorbent, reactive layer or fuel fuseKALAYCI VELI E·Filed 2012·Granted Oct 15, 2013·17 cites·25 claims
- 3393US6669059B2System and method for passage rinseFiled 2003·Granted Dec 30, 2003·175 cites·38 claims
- 3484US9993584B2Nasal aspiratorNEILMED PHARMACEUTICALS INC·Filed 2015·Granted Jun 12, 2018·7 cites·11 claims
- 3584US2022168432A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2022·Application pending·0 cites
- 3683US11590081B1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2018·Granted Feb 28, 2023·1 cites·37 claims
- 3783US11590228B1Extended release amphetamine compositionsTRIS PHARMA INC·Filed 2019·Granted Feb 28, 2023·1 cites·18 claims
- 3881US9884148B2Angular cap for dispensing liquidsMEHTA KETAN C·Filed 2015·Granted Feb 6, 2018·3 cites·22 claims
- 3981US8343114B2Nasal rinse tipMEHTA KETAN C·Filed 2009·Granted Jan 1, 2013·17 cites·12 claims
- 4081US2025064747A1Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2024·Application pending·0 cites
- 4180US12076441B2Extended release amphetamine tabletsTRIS PHARMA INC·Filed 2023·Granted Sep 3, 2024·0 cites·6 claims
- 4280USD779055SAspiratorMEHTA KETAN C·Filed 2015·Granted Feb 14, 2017·20 cites·1 claims
- 4380US2023165837A1Novel clonidine formulationTRIS PHARMA INC·Filed 2022·Application pending·0 cites
- 4479US10973960B2Nasal aspiratorNEILMED PHARMACEUTICALS INC·Filed 2018·Granted Apr 13, 2021·3 cites·20 claims
- 4579US10556056B2Angular cap for dispensing liquidsMEHTA KETAN C·Filed 2018·Granted Feb 11, 2020·2 cites·18 claims
- 4679US2019151460A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2019·Application pending·0 cites
- 4779US2021162055A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2021·Application pending·0 cites
- 4877US2021038734A1Modified release formulations containing drug-ion exchange resin complexesTRIS PHARMA INC·Filed 2020·Application pending·0 cites
- 4976US2010087501A1Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer ComplexBVM HOLDING CO·Filed 2009·Application pending·0 cites
- 5075USD779054SAspiratorMEHTA KETAN C·Filed 2015·Granted Feb 14, 2017·16 cites·1 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ketan Mehta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →